Co-founders of San Francisco biotech startup uBiome charged with fraud

[DearWallstreet.com] DWS Daily on Mar 18, 2021 EMAIL}/redirect [Co-founders of San Francisco biotech startup uBiome charged with fraud Jonathan Stempel]( Image]( By Jonathan Stempel NEW YORK (Reuters) - U.S. prosecutors on Thursday charged the co-founders of uBiome Inc, a San Francisco biotechnology startup, with defrauding investors about its ability to expand clinical tests to monitor gut health and obtain reimbursements from insurers. Zachary Apte and Jessica Richman were accused of raising more than $76 million in two fundraising rounds while misleading investors about uBiome's revenue growth and reimbursement rates, the medical community's lack of acceptance for its tests, and their reliance on a "captive" group of doctors for testing. Apte, 36, and Richman, 46, each face more than 40 criminal counts including healthcare, securities and wire fraud, with maximum penalties totaling several hundred years in prison, the U.S. Department of Justice said. The Securities and Exchange Commission filed related civil charges. Lawyers for the defendants did not immediately respond to requests for comment. Thursday's charges follow uBiome's Sept. 2019 bankruptcy filing and subsequent closure. The FBI had raided uBiome's headquarters the previous April. Founded in 2012, uBiome's business focused on testing microbiomes, located in the gut and elsewhere in the body, through such tests as Gut Explorer, SmartGut and SmartJane. Customers could buy mail-order kits, collect samples from home, complete surveys, and get results online in a few weeks. According to prosecutors, many tests were not clinically validated or medically necessary, and the defendants' fraudulent practices included rewarding gift cards to patients who returned samples. Prosecutors said the fraud ran from late 2015 through early 2019, with Richman trying to stoke press interest by pretending to be younger than she was. The defendants "turned a blind eye to compliance and pursued at all costs a path designed to bring the greatest investment in their company," Acting U.S. Attorney Stephanie Hinds in San Francisco said. Hinds' office is also prosecuting Theranos Inc founder Elizabeth Holmes, who has pleaded not guilty to defrauding investors and patients by claiming her startup could conduct a large array of medical tests with a few drops of blood. (Reporting by Jonathan Stempel in New York; Editing by Bill Berkrot) [Ford to only partially assemble some vehicles, idle two plants due to global chip shortage]( DETROIT (Reuters) - Ford Motor Co said on Thursday it will build its flagship, highly profitable...([Continue Reading]( EMAIL}/redirect [Fed Chair Powell to give speech on Monday, testify Tuesday and Wednesday]( By Ann Saphir (Reuters) - Federal Reserve Chair Jerome Powell is scheduled to spea...([Continue Reading]( [Nike misses quarterly revenue estimates on temporary store closures]( (Reuters) - Nike Inc fell short of Wall Street estimates for third-quarter revenue on Thursday, ...([Continue Reading]( EMAIL}/redirect GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.This is a PAID ADVERTISEMENT provided to customers/subscribers of dearwallstreet. Although we have sent you this email, dearwallstreet does NOT specifically endorse this product nor is it responsible for the content of this message. Furthermore, we make no guarantee or warranty about what is advertised above. DISCLAIMER: In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that dearwallstreet. "DWS" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this message. DWS has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this message, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should call your State Securities Administrator to determine if the security may be sold in your State. Many companies have information filed with State securities regulators who may be able to supply you with additional information. You also should read and review, if and to the extent available, any information concerning an advertised company available at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at and the Financial Industry Regulatory Authority (the "FINRA") at . We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud at as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence. You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertised company, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company. dearwallstreet.com is affilated with interactiveoffers.com. Rua Frei Tomé de Jesus n. 18 1 dto. Lisboa Lisboa 1700-215 PORTUGAL [Unsubscribe]( | [Change Subscriber Options](